Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Chouaid

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|June 15, 2013
Treatment of lung cancer: will financial issues become a criterion of choice?Alain Vergnenegre, Isabelle Borget, Christos Chouaid
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 5, 2025
Comorbidities in Lung Cancer Screening: A Key to Finding the Right Spot or Opening Pandora's Box?Sebastien Gendarme, Christos Chouaid, Edwin Ostrin
Current Oncology (Toronto, Ont.)|February 24, 2022
<i>ROS-1</i> Fusions in Non-Small-Cell Lung Cancer: Evidence to DateSébastien Gendarme, Olivier Bylicki, Christos Chouaid, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 14, 2024
Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors-a questionnaire studyFlorian Scotté, Pascal Artru, Mahasti Saghatchian, et al.
Plos One|June 22, 2016
Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in FranceKokuvi Atsou, Perrine Crequit, Christos Chouaid, et al.
Chest|August 23, 2008
Cost-benefit analysis of a simulated institution-based preoperative smoking cessation intervention in patients undergoing total hip and knee arthroplasties in FranceGilles Hejblum, Kokuvi Atsou, Bertrand Dautzenberg, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2012
Cutaneous lymphangitis carcinomatosa in a patient with lung adenocarcinoma: case report and literature reviewLola Prat, Christos Chouaid, Adrien Kettaneh, et al.
Pharmacoeconomics|March 4, 2009
Economics of treatments for non-small cell lung cancerChristos Chouaid, Kukovi Atsou, Gilles Hejblum, et al.
Cancer Chemotherapy and Pharmacology|December 15, 2010
A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancerChristos Chouaid, Faith Nathan, Kristine Pemberton, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2026
Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC-Considerations for Broader ApplicabilityRomain Supiot, Léopoldine du Manoir de Juaye, Christos Chouaid
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Expert Review of Pharmacoeconomics & Outcomes Research|June 15, 2013
Treatment of lung cancer: will financial issues become a criterion of choice?Alain Vergnenegre, Isabelle Borget, Christos Chouaid
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 5, 2025
Comorbidities in Lung Cancer Screening: A Key to Finding the Right Spot or Opening Pandora's Box?Sebastien Gendarme, Christos Chouaid, Edwin Ostrin
Current Oncology (Toronto, Ont.)|February 24, 2022
<i>ROS-1</i> Fusions in Non-Small-Cell Lung Cancer: Evidence to DateSébastien Gendarme, Olivier Bylicki, Christos Chouaid, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 14, 2024
Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors-a questionnaire studyFlorian Scotté, Pascal Artru, Mahasti Saghatchian, et al.
Plos One|June 22, 2016
Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in FranceKokuvi Atsou, Perrine Crequit, Christos Chouaid, et al.
Chest|August 23, 2008
Cost-benefit analysis of a simulated institution-based preoperative smoking cessation intervention in patients undergoing total hip and knee arthroplasties in FranceGilles Hejblum, Kokuvi Atsou, Bertrand Dautzenberg, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2012
Cutaneous lymphangitis carcinomatosa in a patient with lung adenocarcinoma: case report and literature reviewLola Prat, Christos Chouaid, Adrien Kettaneh, et al.
Pharmacoeconomics|March 4, 2009
Economics of treatments for non-small cell lung cancerChristos Chouaid, Kukovi Atsou, Gilles Hejblum, et al.
Cancer Chemotherapy and Pharmacology|December 15, 2010
A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancerChristos Chouaid, Faith Nathan, Kristine Pemberton, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2026
Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC-Considerations for Broader ApplicabilityRomain Supiot, Léopoldine du Manoir de Juaye, Christos Chouaid
Pageof 21